EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinically Accessible Liver Fibrosis Association with CT Scan Coronary Artery Disease Beyond Other Validated Risk Predictors: The ICAP Experience

Belén García Izquierdo iD, Diego Martínez-Urbistondo, Sonsoles Guadalix, Marta Pastrana iD, Ana Bajo Buenestado, Inmaculada Colina, Manuel García de Yébenes, Gorka Bastarrika, José A Páramo iD, Juan Carlos Pastrana iD

Journal of Clinical Medicine · 13.02.2025 · 14 (4) · 1218

DOI: 10.3390/jcm14041218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.02.2025. Verfasst von Belén García Izquierdo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Clínica Universidad de Navarra, 28027 Madrid, Spain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Evidenze foundation, InnovaRCV grant for CV risk research 2024 (Evidenze foundation).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/objectives: Cardiovascular risk (CVR) stratification in clinical settings remains limited. This study aims to evaluate clinical parameters that could improve the identification of higher-than-expected coronary artery disease (CAD) in CT scan coronarography.

Methods

In a cross-sectional study of asymptomatic patients from the Integrated Cardiovascular Assessment Program (ICAP), volunteers aged 40–80 without diagnosed cardiovascular disease were assessed. CVR factors like obesity, lipid and glucose profiles, liver fibrosis risk (FIB-4 ≥ 1.3), C-reactive protein, and family history of CVD were evaluated. Patients were stratified by CVR following ESC guidelines. “CVR excess” was defined as CAD-RADS ≥ 2 in low-to-moderate-risk (LMR), CAD-RADS ≥ 3 in high-risk (HR), and CAD-RADS ≥ 4 in very-high-risk (VHR) groups.

Results

Among 219 patients (mean age 57.9 ± 1.15 years, 14% female), 43.4% were classified as LMR, 49.3% as HR, and 7.3% as VHR. “CVR excess” was observed in 18% of LMR, 15% of HR, and 19% of VHR patients. LMR patients with prior statin use and HR patients with obesity were more likely to have “CVR excess” (p < 0.01 and p < 0.05, respectively). FIB-4 modified the effect of statin use and obesity on “CVR excess” prediction (p for interactions < 0.05). Models including age, sex, and both interactions showed a strong discrimination for “CVR excess” in LMR and HR groups (AUROC 0.84 (95% CI 0.73–0.95) and 0.82 (95% CI 0.70–0.93), respectively).

Conclusions

Suspected liver fibrosis combined with statin use in LMR patients and obesity in HR patients is associated with CVR excess, providing potential indications for image CAD assessment in asymptomatic patients.

Schlagwörter

Stichwörter der Autor:innen

atherosclerotic disease burdencardiovascular risk assessmentliver fibrosisobesitystatin use

Autor:innen und Institutionen

  • Department of Endocrinology, Clínica Universidad de Navarra, 28027 Madrid, Spain.
  • Vascular Medicine Area, Clínica Universidad de Navarra, 28027 Madrid, Spain.
  • Department of Internal Medicine, Clínica Universidad de Navarra, 28027 Madrid, Spain.
  • Department of Internal Medicine, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
  • Department of Cardiology, Clínica Universidad de Navarra, 28027 Madrid, Spain.
  • Department of Radiology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.

ORCID-Profile: Belén García Izquierdo, Marta Pastrana, José A Páramo, Juan Carlos Pastrana

Förderung

  • Evidenze foundation
  • InnovaRCV grant for CV risk research 2024 (Evidenze foundation)

Zitieren

APA

García Izquierdo, B., Martínez-Urbistondo, D., Guadalix, S., Pastrana, M., Bajo Buenestado, A., Colina, I., García de Yébenes, M., Bastarrika, G., Páramo, J. A., & Pastrana, J. C. (2025). Clinically Accessible Liver Fibrosis Association with CT Scan Coronary Artery Disease Beyond Other Validated Risk Predictors: The ICAP Experience. Journal of Clinical Medicine, 14(4), 1218. https://doi.org/10.3390/jcm14041218

Vancouver

García Izquierdo B, Martínez-Urbistondo D, Guadalix S, Pastrana M, Bajo Buenestado A, Colina I, et al. Clinically Accessible Liver Fibrosis Association with CT Scan Coronary Artery Disease Beyond Other Validated Risk Predictors: The ICAP Experience. Journal of Clinical Medicine. 2025;14(4):1218. doi:10.3390/jcm14041218

BibTeX
@article{GarcaIzquierdo2025,
  author = {García Izquierdo, Belén and Martínez-Urbistondo, Diego and Guadalix, Sonsoles and Pastrana, Marta and Bajo Buenestado, Ana and Colina, Inmaculada and García de Yébenes, Manuel and Bastarrika, Gorka and Páramo, José A and Pastrana, Juan Carlos},
  title = {Clinically Accessible Liver Fibrosis Association with CT Scan Coronary Artery Disease Beyond Other Validated Risk Predictors: The ICAP Experience},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {1218},
  doi = {10.3390/jcm14041218}
}
Kostenlos starten →